QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.0067
-- x --
-- x --
-- - --
$ 0.00 - $ 0.21
2
na
nm
$ 7.28
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 humanigen-downfall-fda-rejection-for-covid-19-drug-triggers-financial-crisis-bankruptcy

Humanigen, previously linked with disgraced pharmaceutical entrepreneur Martin Shkreli, reported $44.1 million in debt.

 crude-oil-up-1-verizon-earnings-beat-views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Do...

 why-alaska-air-group-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 56 companies set new 52-week lows.

 dow-surges-50-points-general-electric-profit-tops-expectations

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 50 points on Tuesday. The Dow traded up...

 nasdaq-rises-70-points-general-motors-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 70 points on Tuesday. Following the market ope...

 why-squarespace-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.

 why-clene-shares-are-trading-lower-by-20-here-are-20-stocks-moving-premarket

Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was ...

 humanigen-granted-us-patent-titled-method-of-increasing-the-efficacy-of-car-t-immunotherapy-using-lenzilumab

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11673962

 humanigens-lenzilumab-being-studied-as-a-potential-first-treatment-in-thirty-years-with-a-novel-mechanism-of-action-for-chronic-myelomonocytic-leukemia-cmml-an-orphan-form-of-leukemia

  CMML is an aggressive, poorly understood cancer; approximately 20% of patients survive three years from diagnosis E...

 why-eastside-distilling-shares-are-trading-lower-by-over-25-here-are-20-stocks-moving-premarket

Gainers Hitek Global Inc. (NASDAQ: HKIT) jumped 25.5% to $6.98 in pre-market trading after gaining 11% on Friday. Hitek Glob...

 credit-suisse-reiterates-underperform-on-humanigen-maintains-05-price-target

Credit Suisse analyst Tiago Fauth reiterates Humanigen (NASDAQ:HGEN) with a Underperform and maintains $0.5 price target.

 why-sabre-are-trading-lower-by-19-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION